'김갑성' 기자의 전체기사
-
Getinge Interim Report July-September 2025: High organic sale…
GOTHENBURG, Sweden, Oct. 21, 2025 -- "We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company's net sales increased organically by 9,5% while order intake rose by 4,7% organically. Acute Care Therapies continued to meet the higher demand for ventilators, in the wake of an ongoing market consolidation. Order intake and sales of ECLS consumables were also significant. Both Life Science and
- 김갑성 기자
- 2025-10-21 14:45
-
Abbott and BIG CARiNG Group Launch Nationwide Influenza Aw…
KUALA LUMPUR, Malaysia, Oct. 21, 2025 -- Abbott, a global healthcare leader, and BIG CARiNG Group (BCG), one of Malaysia's largest retail pharmacies, announced a strategic three-year collaboration to promote influenza awareness across Malaysia. The Influenza Awareness Program, running from 2025 to 2027, is designed to elevate public understanding of influenza and encourage proactive health management. This nationwide initiative reflects a shared commitment to improving community health outcomes through education, engagement, and accessible healthcare information. Through a phased rollo
- 김갑성 기자
- 2025-10-21 13:12
-
Biomom Partners with Kolmar BNH to Enhance "Biomom Snow" --…
SEOUL, South Korea, Oct. 21, 2025 -- Health supplement brand Biomom has renewed its flagship children's probiotic, "Biomom Snow," with enhanced quality and improved flavor. As part of the renewal, Biomom selected Kolmar BNH Co., Ltd. as its new manufacturing partner, reinforcing its commitment to consumer satisfaction and product innovation Biomom Snow contains 10 billion CFU probiotics per stick, using 19 strains certified by the Korean Ministry of Food and Drug Safety (MFDS). It also includes essential nutrients such as Vitamin B complex, Vitamin D, folic acid
- 김갑성 기자
- 2025-10-21 11:00
-
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a N…
TAIPEI and SAN DIEGO, Oct. 21, 2025 -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological artificial intelligence (AI) system. DeepMind reported that its latest AI model successfully generated and experimentally validated a new hypothesis for cancer treatment, calling it "a milestone for AI in science." Through large-scale analysis of tumor cell data and more than 4,000 potential drug candidates, DeepMind's model
- 김갑성 기자
- 2025-10-21 10:49
-
Zero Formalin Specimen Preservation Solution for Formalin-Fre…
BANGKOK, Oct. 21, 2025 -- Anatomy instructors at the Faculty of Veterinary Science, Chulalongkorn University, have developed Zero Formalin (ZF)—a formalin-free animal specimen preservation solution—to create safer classrooms and reduce health risks for students and staff. The solution is now used for all animal bodies in anatomy classes. In order to become veterinarians, students at the Faculty of Veterinary Science must spend a long period studying anatomy. They examine animal cadavers that have been preserved using formalin—a clear, highly toxic chemical with a strong, punge
- 김갑성 기자
- 2025-10-21 10:00
-
SK Biopharmaceuticals Launches Joint Venture with Eurofa…
[ 메디채널 김갑성 기자 ] SK Biopharmaceuticals forms a joint venture, Mentis Care, to develop an integrated epilepsy care ecosystem through AI-driven platform commercialization. SEOUL, South Korea, Oct. 21, 2025 -- SK Biopharmaceuticals, Co., Ltd., a biotech company focusing on research, development, and commercialization of treatments for disorders of the central nervous system (CNS) and oncology worldwide, today announced the establishment of Mentis Care, Inc., a joint venture with a leading Brazil-based pharmaceutical company, Eurofarma, with presence in 24 countries, including North Ameri
- 김갑성 기자
- 2025-10-21 09:20
-
Shimadzu Asia Pacific Celebrates 150th Anniversary -A Centur…
SINGAPORE, Oct. 21, 2025 -- Shimadzu Asia Pacific joins the global celebration of Shimadzu Corporation's 150th anniversary, marking a century and a half of pioneering innovations that have shaped science, technology, and healthcare worldwide. "As we celebrate 150 Years of Innovation, we remain committed to contributing to society through science and technology. Together with our partners, customers, and employees, we will continue developing solutions that address key challenges and create value across Asia Pacific and beyond," said Prem Anand, Managing Direct
- 김갑성 기자
- 2025-10-21 09:00
-
NSG Bio Launches NSG BioSuites at Geneo - A New Product, La…
SINGAPORE, Oct. 21, 2025 -- NSG Bio, a leading provider of flexible and high-quality biotech laboratory spaces, announced the launch of its latest product, NSG BioSuites, located at the brand-new Geneo development in Singapore Science Park. This marks NSG Bio's fourth site in Singapore and also its largest facility to date, representing a significant step forward in providing innovative, accessible solutions for the biotech community. NSG BioSuites is the company's newest offering: small to large, affordable private lab suites purpose-built for biotech teams ready
- 김갑성 기자
- 2025-10-21 08:00
-
LabConnect Featured in Season Finale of Emmy-Nominated…
JOHNSON CITY, Tenn., Oct. 21, 2025 -- LabConnect, a leading provider of global central laboratory and support services for clinical trials, will be featured on the season 9 finale of the innovation-focused TV series, Tomorrow's World Today. Premiering on Science Channel on November 8, the episode explores how LabConnect is redefining clinical trial support as a technology-first partner for pharma and biotech. Tomorrow's World Today is an Emmy-nominated and Telly Award winning series exploring the latest advancements in science, sustainability, innovation, and technology. Airing
- 김갑성 기자
- 2025-10-21 01:11
-
Benchling Partners with Anthropic to Build a Bridge Between S…
Claude's Life Sciences Ecosystem pairs Benchling AI with advanced reasoning in Claude SAN FRANCISCO, Oct. 21, 2025 -- Benchling today announced a partnership with Anthropic, an AI safety and research company and the creator of Claude, to advance AI in biotech through the Claude for Life Sciences Ecosystem. The collaboration pairs Benchling's trusted data foundation and AI agents with Claude's advanced reasoning capabilities. Scientists can now ask Claude questions about their Benchling data to get clear, source-linked answers, summaries, and decision-ready reports in minutes. B
- 김갑성 기자
- 2025-10-21 00:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-13_SAT
- Official streaming platform for the Games of the Future Abu Dhabi 2025 powered by ADNOC launches ahead of opening competition 21:57
- フォーミュラ1エティハド航空アブダビグランプリ（Formula 1 Etihad Airways Abu Dhabi Grand Prix）、ヤス島に339,000人のファンを動員 19:05
- SmallRig and FamilyLens Launch Global Family Filmmaking Initiative at 3rd FamilyLens International Film Festival 13:10
- 「FUJIYA」新ビジュアルアイデンティティと「Tenjincho Place」、2025年度台湾ゴールデンピンデザイン賞に輝く 10:47
- ALL CONEC Signs MOU with MINIMAX to Accelerate Global Digital Dental Expansion 08:00
- Introducing CASEKOO Rouge. The Gold Standard. 06:00
- NETMARBLE REVEALS NEW TRAILER FOR THE SEVEN DEADLY SINS: ORIGIN AT THE GAME AWARDS 2025 03:00
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 13일 23시 40분